IMV INC

IMV Inc Inc. applies its novel adjuvanting platform to the development of vaccines for cancer therapy, infectious diseases and animal health. The Company’s DepoVax™ platform is a patented formulation that provides controlled and prolonged exposure of antigens plus adjuvant to the immune system. IMV Inc has advanced two DepoVax-based cancer vaccines into Phase I human clinical trials. The Company is also advancing a broad infectious disease pipeline including vaccines in such indications as malaria, respiratory syncytial virus (RSV) and anthrax. In addition to the Company’s human health vaccine strategy, it continues to capture value from animal health vaccine applications. IMV Inc has key partnerships in the animal health sector including an agreement with Pfizer Animal Health.
IMV INC
Industry:
Biotechnology Health Diagnostics Therapeutics
Founded:
2000-01-01
Address:
Halifax, Nova Scotia, Canada
Country:
Canada
Website Url:
http://www.imvaccine.com
Total Employee:
11+
Status:
Active
Contact:
19024920888
Total Funding:
71.16 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy RapidSSL Akamai Hosted Campaign Monitor Widget
Current Advisors List
Board_member
2020-07-01
Board_member
2018-06-01
Founder
Stock Details
Investors List
Horizon Technology Finance
Horizon Technology Finance investment in Post-IPO Debt - IMV Inc
Lumira Ventures
Lumira Ventures investment in Post-IPO Equity - IMV Inc
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Post-IPO Equity - IMV Inc
Altium Capital
Altium Capital investment in Post-IPO Equity - IMV Inc
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Post-IPO Equity - IMV Inc
Brigus Capital
Brigus Capital investment in Private Equity Round - IMV Inc
Key Employee Changes
Date | New article |
---|---|
2021-06-09 | IMV Announces Appointment of Jeremy R. Graff, Ph.D. as Chief Scientific Officer And Addition of Clinical Advisor |
Official Site Inspections
http://www.imvaccine.com
- Host name: ip-70-32-77-8.ip.secureserver.net
- IP address: 70.32.77.8
- Location: Culver City United States
- Latitude: 34.0141
- Longitude: -118.3983
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90232

More informations about "IMV Inc"
IMV Inc - Crunchbase Company Profile & Funding
IMV Inc Inc. applies its novel adjuvanting platform to the development of vaccines for cancer therapy, infectious diseases and animal health. The Company’s …See details»
TMX TSX | TSXV | News | New Company Listings - TSX.com
Nov 26, 2014 Marc Mansour Tel.: (902) 492-1819, ext. 2 MMansour@imvaccine.com-or-Kimberly Stephens Tel.: (902) 492-1819, ext. 3 KStephens@imvaccine.com: Incorporation: …See details»
Immunovaccine Company Profile | Management and Employees …
Find contact information for Immunovaccine. Learn about their Research & Development, Business Services market share, competitors, and Immunovaccine's email format.See details»
Home - Vaccine and Infectious Disease Organization
Apr 21, 2025 Protecting the world from infectious diseases has never been more urgent. The Vaccine and Infectious Disease Organization (VIDO) is a global leader in infectious disease …See details»
Immunovaccine - Overview, News & Similar companies - ZoomInfo
Who is Immunovaccine. Immunovaccine Inc. (TSX-V:IMV) is a clinical stage vaccine development company focused on the commercialization of its patented DepoVax vaccine del ivery …See details»
Immunovaccine | Halifax, NS, Canada Startup - gust.com
Immunovaccine is a clinical-stage vaccine development company focused on advancing its patented DepoVax™ vaccine for cancer therapy.See details»
Check us out! We are thrilled and excited to announce the
May 29, 2017 This new identity marks a major step forward in updating and re-establishing our brand. Our team at Immunovaccine has put a considerable amount of time and effort in …See details»
Immunovaccine Inc. Management Team | Org Chart - RocketReach
Immunovaccine Inc. employs 147 employees. The Immunovaccine Inc. management team includes Marianne Stanford (Vice President Research and Development), Stephan Fiset (Vice …See details»
ImmunoVaccine - VentureRadar
Morpheus Biolabs USA n/a Morpheus BioLabs is a Contract Research Organization (CRO) that is specialized in providing biomedical research and consulting services to pharmaceuticals, biotechnology firms, CRO partners, and small to mid-size research and discovery organizations. The company's area of expertise is broad, which encompasses immunology, auto-immunity, …See details»
Immunovaccine to Host Annual General Meeting :: IMV Inc. (IMV)
Contacts: Immunovaccine Inc. Kimberly Stephens CFO (902) 492-1819 info@imvaccine.com www.imvaccine.com Vida Communication (media) Tim Brons (415) 675-7402 …See details»
Immunize.org Partners | Immunize.org - Immunization Action …
Jun 7, 2024 The Sabin Vaccine Institute is a non-profit organization dedicated to developing new vaccines, advocating for increased use of existing vaccines, and promoting expanded access …See details»
Immunovaccine: Employee Directory | ZoomInfo.com
Immunovaccine Employee Directory . Immunovaccine corporate office is located in 1344 Summer St Ste 412, Halifax, Nova Scotia, B3H 0A8, Canada and has 7 employees.See details»
Vaccines and immunization - World Health Organization (WHO)
6 days ago Vaccination is a simple, safe, and effective way of protecting people against harmful diseases, before they come into contact with them. It uses your body’s natural defences to …See details»
Vaccine Abbreviations | Vaccines & Immunizations | CDC
Aug 1, 2024 A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS. A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. Vaccines & Immunizations Explore Topics Search.See details»
Im - Vaccine (@imvaccine) • Instagram photos and videos
30 Followers, 10 Following, 3 Posts - See Instagram photos and videos from Im - Vaccine (@imvaccine)See details»
Vaccines and immunization - Canada.ca
Government of Canada health information and facts about vaccination for children, adults, COVID-19, travel, during pregnancy, safety and side effects, information for health professionals.See details»
Canada’s Vaccine and Infectious Disease Organization Bolsters …
Jan 17, 2024 The Vaccine and Infectious Disease Organization (VIDO), is becoming Canada’s Centre for Pandemic Research, preparing Canada for emerging health threats by expanding its expertise and infrastructure. This includes opening a new Vaccine Development Centre (VDC) to manufacture vaccines; constructing a new multispecies animal housing facility; enhancing its …See details»
Mpox Vaccine (Imvamune®) Guidance for Health Care Providers
1 | Page Ministry of Health . Mpox. Vaccine (Imvamune®) Guidance for Health Care Providers . Version 4.0 – February 23, 2024. This guidance provides basic informatioly.n Thonis …See details»
Vaccine administration practices: Canadian Immunization Guide
Vaccine administration. Vaccines should be administered to the right person using the correct indication, correct vaccine, correct dose, correct route of administration, correct injection site (if …See details»
Interim guidance on the use of Imvamune - Canada
Efficacy/effectiveness of Imvamune ® pre-exposure vaccination against mpox. NACI reviewed available evidence on efficacy/effectiveness and safety of Imvamune ® as pre-exposure …See details»